Pfizer, on behalf of its subsidiary Biohaven Pharmaceutical Holding Company, agreed to pay $59,746,277 to resolve allegations that prior to Pfizer's acquisition, Biohaven paid kickbacks to physicians ...
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...
These four top dividend stocks offer dependable passive income streams and solid total return, and they are too cheap to ...
Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Havas Health Network has rebranded a U.K. agency. Havas Life Medicom is now Havas Life London, a group focused on brand, ...
Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe ...
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
Pfizer will pay nearly $60 million to settle allegations that Biohaven, a company it acquired, paid kickbacks to healthcare ...
First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...
The American Chamber of Commerce in Thailand (AMCHAM) recently held its annual Strategy Session, bringing together its Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback